WOBURN, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Anika Therapeutics, Inc. announced today that Kevin Quinlan, chief financial officer, will be presenting at the Rodman & Renshaw 8th Annual Global Healthcare Conference on Tuesday, November 7, 2006 at 9:30 a.m. (ET). The conference is being held at the New York Palace Hotel in New York, NY.
A live audio webcast of the presentation will be available through the Rodman & Renshaw website at: http://www.wsw.com/webcast/rrshq10/anik/. The live broadcast will also be available through the investor relations section of Anika’s website at http://www.anikatherapeutics.com. An archive webcast will be available for three months following the event.
About Anika Therapeutics, Inc.
Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (http://www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika products include OrthoVisc(R), a treatment for osteoarthritis of the knee available internationally and marketed in the U.S. by DePuy Mitek, and Hyvisc(R), a treatment for equine osteoarthritis marketed in the U.S. by Boehringer Ingelheim Vetmedica, Inc. Anika manufactures Amvisc(TM) and Amvisc Plus(TM), HA viscoelastic products for ophthalmic surgery. It also produces STAARVISC(TM)-II, which is distributed by STAAR Surgical company and Shellgel(TM) for Cytosol Ophthalmics, Inc.
CONTACTS: Kevin Quinlan David Calusdian Anika Therapeutics, Inc. Sharon Merrill Associates, Inc. (781) 932-6616 (617) 542-5300 anik@investorrelations.com
Anika Therapeutics, Inc.
CONTACT: Kevin Quinlan of Anika Therapeutics, Inc., +1-781-932-6616; orDavid Calusdian of Sharon Merrill Associates, Inc. for Anika Therapeutics,Inc., +1-617-542-5300, anik@investorrelations.com
Web site: http://www.anikatherapeutics.com/
